Insider transactions

EDGAR

PRECIGEN, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
1 transactions, 3,411 shares
Sum of shares × price per share: 24,661.53
Open-market sales (code S)
40 transactions, 9,179,269 shares
Sum of shares × price per share: 36,088,207.5483

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 151

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,7444.72
50,711.68

Derived: shares × price per share. Exact value 50711.68.

268,993Direct (D) No— Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)42,9182.33
99,998.94

Derived: shares × price per share. Exact value 99998.94.

311,911Direct (D) No— Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20.96
1.92

Derived: shares × price per share. Exact value 1.92.

311,913Direct (D) No— Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11.21
1.21

Derived: shares × price per share. Exact value 1.21.

311,914Direct (D) No— Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (10,744) — exercise price 4.72
Disposed (D)10,7440—169,256Direct (D) No
F1
  • F1 The options are fully vested.
Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (42,918) — exercise price 2.33
Disposed (D)42,9180—157,082Direct (D) No
F1
  • F1 The options are fully vested.
Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (2) — exercise price 0.96
Disposed (D)20—46,813Direct (D) No
F1
  • F1 The options are fully vested.
Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (1) — exercise price 1.21
Disposed (D)10—520,999Direct (D) No
F2
  • F2 The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter.
Open filing 0000950103-26-014457 Read from the filing’s XML Dispute this row
2026-08-26 Filed 2026-08-28KINDLER JEFFREY B Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)185,0007.44
1,376,400

Derived: shares × price per share. Exact value 1376400.00.

17,100Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Open filing 0000950103-26-013201 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)79,1661.61
127,457.26

Derived: shares × price per share. Exact value 127457.26.

221,158Direct (D) Yes— Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)79,1667.5
593,745

Derived: shares × price per share. Exact value 593745.0.

141,992Direct (D) Yes
F3
  • F3 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (79,166) — exercise price 1.61
Disposed (D)79,1660—120,834Direct (D) Yes
F5
  • F5 The stock options vested 25% on July 22, 2025 and in equal monthly installments for three years thereafter.
Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,3422.33
35,746.86

Derived: shares × price per share. Exact value 35746.86.

484,207Direct (D) Yes— Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,3427.5
115,065

Derived: shares × price per share. Exact value 115065.0.

468,865Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (15,342) — exercise price 2.33
Disposed (D)15,3420—73,304Direct (D) Yes
F4
  • F4 The stock options are fully vested.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,208——144,577Direct (D) Yes
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,5857.20
18,612

Derived: shares × price per share. Exact value 18612.00.

141,992Direct (D) Yes
F2
  • F2 Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Tennant Phil Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (5,208)
Disposed (D)5,2080—57,292Direct (D) Yes
F1, F4
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
  • F4 Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Open filing 0000950103-26-012871 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,291——261,826Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
Open filing 0000950103-26-012873 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Thomasian Harry Jr. Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,5777.20
25,754.4

Derived: shares × price per share. Exact value 25754.40.

258,249Direct (D) No
F2
  • F2 Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Open filing 0000950103-26-012873 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Thomasian Harry Jr. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (7,291)
Disposed (D)7,2910—80,209Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
  • F3 Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Open filing 0000950103-26-012873 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,500——472,512Direct (D) Yes
F2
  • F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,6477.20
26,258.4

Derived: shares × price per share. Exact value 26258.40.

468,865Direct (D) Yes
F3
  • F3 Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (7,500)
Disposed (D)7,5000—57,292Direct (D) Yes
F2, F5
  • F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
  • F5 Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Lehr Donald P. Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,208——760,669Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
Open filing 0000950103-26-012874 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Lehr Donald P. Officer: Chief Legal Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)2,4887.20
17,913.6

Derived: shares × price per share. Exact value 17913.60.

758,181Direct (D) No
F2
  • F2 Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Open filing 0000950103-26-012874 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Lehr Donald P. Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (5,208)
Disposed (D)5,2080—57,292Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
  • F3 Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Open filing 0000950103-26-012874 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Sabzevari Helen Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)20,833——3,789,705Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
Open filing 0000950103-26-012870 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Sabzevari Helen Officer: President and CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)10,1847.20
73,324.8

Derived: shares × price per share. Exact value 73324.80.

3,779,521Direct (D) No
F2
  • F2 Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Open filing 0000950103-26-012870 Read from the filing’s XML Dispute this row
2026-08-23 Filed 2026-08-25Sabzevari Helen Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (20,833)
Disposed (D)20,8330—229,167Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Precigen common stock.
  • F3 Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.
Open filing 0000950103-26-012870 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)34,6582.33
80,753.14

Derived: shares × price per share. Exact value 80753.14.

499,670Direct (D) Yes— Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)34,6587.50
259,935

Derived: shares × price per share. Exact value 259935.00.

465,012Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (34,658) — exercise price 2.33
Disposed (D)34,6580—88,646Direct (D) Yes
F4
  • F4 The stock options are fully vested.
Open filing 0000950103-26-012872 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25AGEE NANCY H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,4117.23
24,661.53

Derived: shares × price per share. Exact value 24661.53.

309,187Direct (D) No— Open filing 0000950103-26-012875 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-07Shah Rutul R Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)32,7396.86
224,589.54

Derived: shares × price per share. Exact value 224589.54.

465,012Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person
Open filing 0000950103-26-012078 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-03Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)33,7722.33
78,688.76

Derived: shares × price per share. Exact value 78688.76.

531,523Direct (D) Yes— Open filing 0000950103-26-011711 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-03Shah Rutul R Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)33,7726.50
219,518

Derived: shares × price per share. Exact value 219518.00.

497,751Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Open filing 0000950103-26-011711 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-03Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (33,772) — exercise price 2.33
Disposed (D)33,7720—123,304Direct (D) Yes
F2
  • F2 The stock options are fully vested.
Open filing 0000950103-26-011711 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-07-31Thomasian Harry Jr. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)100,0006.06
606,000

Derived: shares × price per share. Exact value 606000.00.

254,535Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Open filing 0000950103-26-011578 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-01Thomasian Harry Jr. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)171,4295.53
948,002.37

Derived: shares × price per share. Exact value 948002.37.

354,535Direct (D) Yes
F1, F3
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.39 to $5.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Open filing 0000950103-26-009980 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)42,9242.33
100,012.92

Derived: shares × price per share. Exact value 100012.92.

540,675Direct (D) Yes— Open filing 0000950103-26-009979 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Shah Rutul R Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)42,9245.85
251,105.4

Derived: shares × price per share. Exact value 251105.40.

497,751Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Open filing 0000950103-26-009979 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Shah Rutul R Officer: Chief Operating Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (42,924) — exercise price 2.33
Disposed (D)42,9240—157,076Direct (D) Yes
F2
  • F2 The stock options are fully vested.
Open filing 0000950103-26-009979 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Thomasian Harry Jr. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)28,5715.78
165,140.38

Derived: shares × price per share. Exact value 165140.38.

525,964Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.74 to $5.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Open filing 0000950103-26-009980 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Sabzevari Helen Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)346,8362.33
808,127.88

Derived: shares × price per share. Exact value 808127.88.

4,115,708Direct (D) Yes— Open filing 0000950103-26-009978 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Sabzevari Helen Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)346,8365.89
2,042,864.04

Derived: shares × price per share. Exact value 2042864.04.

3,768,872Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Open filing 0000950103-26-009978 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Sabzevari Helen Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option to Purchase Common Stock (Right to Buy) — underlying Common Stock (346,836) — exercise price 2.33
Disposed (D)346,8360—500,164Direct (D) Yes
F3
  • F3 The stock options are fully vested.
Open filing 0000950103-26-009978 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sabzevari Helen Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)119,2504.36
519,930

Derived: shares × price per share. Exact value 519930.00.

3,768,872Direct (D) No
F1
  • F1 Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.
Open filing 0000950103-26-008168 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Lehr Donald P. Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)29,1314.36
127,011.16

Derived: shares × price per share. Exact value 127011.16.

755,461Direct (D) No
F1
  • F1 Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.
Open filing 0000950103-26-008169 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Thomasian Harry Jr. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)41,8844.36
182,614.24

Derived: shares × price per share. Exact value 182614.24.

554,535Direct (D) No
F1
  • F1 Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.
Open filing 0000950103-26-008173 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 263

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Patient Capital Management, LLC 17,950,104 SH153,652,894 dollarsLower by 1,086,872 Prior quarter: 19,036,976Open filing 0001854794-26-000007 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager17,280,537 SH147,921,397 dollarsHigher by 133,616 Prior quarter: 17,146,921Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager10,719,117 SH91,755,642 dollarsLower by 1,283,348 Prior quarter: 12,002,465Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 8,011,028 SH68,574,400 dollarsHigher by 104,868 Prior quarter: 7,906,160Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
TANG CAPITAL MANAGEMENT LLC Partly reported under another manager6,417,500 SH54,933,800 dollarsUnchanged Prior quarter: 6,417,500Open filing 0001214659-26-014410 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager5,087,896 SH43,559,198 dollarsHigher by 68,868 Prior quarter: 5,019,028Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Boxer Capital Management, LLC 4,320,339 SH36,982,101 dollarsLower by 829,661 Prior quarter: 5,150,000Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager4,131,722 SH35,367,544 dollarsHigher by 662,094 Prior quarter: 3,469,628Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Diametric Capital, LP Partly reported under another manager3,917,452 SH33,533,389 dollarsLower by 5,352,474 Prior quarter: 9,269,926Open filing 0001719087-26-000008 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager3,913,408 SH33,498,769 dollarsHigher by 1,343,225 Prior quarter: 2,570,183Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
IRIDIAN ASSET MANAGEMENT LLC/CT Partly reported under another manager3,064,571 SH26,232,728 dollarsLower by 967,392 Prior quarter: 4,031,963Open filing 0001033427-26-000013 Filed 2026-10-23 Dispute this row
Occam Crest Management LP 2,721,521 SH23,296,220 dollarsLower by 884,420 Prior quarter: 3,605,941Open filing 0001493152-26-051816 Filed 2026-11-13 Dispute this row
FIRST TRUST ADVISORS LP 2,623,975 SH22,461,226 dollarsHigher by 609,316 Prior quarter: 2,014,659Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
Nuveen, LLC Partly reported under another manager2,418,938 SH20,706,109 dollarsHigher by 1,716,104 Prior quarter: 702,834Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager2,335,271 SH19,989,920 dollarsHigher by 547,036 Prior quarter: 1,788,235Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 2,307,581 SH19,752,893 dollarsHigher by 96,409 Prior quarter: 2,211,172Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager2,275,300 SH19,476,568 dollarsHigher by 1,394,000 Prior quarter: 881,300Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 2,208,964 SH18,908,732 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Diametric Capital, LP Option: Call Partly reported under another manager1,905,400 SH16,310,224 dollarsHigher by 493,400 Prior quarter: 1,412,000Open filing 0001719087-26-000008 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 1,902,903 SH16,288,850 dollarsHigher by 636,224 Prior quarter: 1,266,679Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,809,486 SH15,489,200 dollarsHigher by 293,633 Prior quarter: 1,515,853Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager1,793,683 SH15,353,927 dollarsHigher by 14,303 Prior quarter: 1,779,380Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager1,574,677 SH13,479,235 dollarsHigher by 795,914 Prior quarter: 778,763Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager1,553,550 SH13,298,388 dollarsHigher by 733,161 Prior quarter: 820,389Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager1,487,610 SH12,733,941 dollarsLower by 360,804 Prior quarter: 1,848,414Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,481,378 SH12,680,599 dollarsLower by 1,925,078 Prior quarter: 3,406,456Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
PRUDENTIAL FINANCIAL INC Partly reported under another manager1,430,538 SH12,245,405 dollarsHigher by 1,276,568 Prior quarter: 153,970Open filing 0001137774-26-000233 Filed 2026-11-16 Dispute this row
Woodline Partners LP 1,401,945 SH12,000,649 dollarsUnchanged Prior quarter: 1,401,945Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager1,354,948 SH11,598,356 dollarsHigher by 423,580 Prior quarter: 931,368Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Caption Management, LLC Option: Call 1,350,300 SH11,558,568 dollarsNot in the prior quarter’s filings read Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,348,084 SH11,539,599 dollarsHigher by 52,136 Prior quarter: 1,295,948Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Tidal Investments LLC Partly reported under another manager1,133,167 SH9,699,910 dollarsNot in the prior quarter’s filings read Open filing 0002000324-26-006122 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager864,579 SH7,041,569 dollarsHigher by 15,281 Prior quarter: 849,298Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
POLEN CAPITAL MANAGEMENT LLC 697,153 SH5,967,630 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005017 Filed 2026-11-13 Dispute this row
ESSEX INVESTMENT MANAGEMENT CO LLC Partly reported under another manager683,419 SH5,850,067 dollarsLower by 22,875 Prior quarter: 706,294Open filing 0000201772-26-000007 Filed 2026-10-19 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 683,268 SH5,848,774 dollarsHigher by 514,097 Prior quarter: 169,171Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager680,975 SH5,829,146 dollarsHigher by 125,745 Prior quarter: 555,230Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager680,537 SH3,440,115 dollarsLower by 345,113 Prior quarter: 1,025,650Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
GMT Capital Corp 668,830 SH5,725,185 dollarsUnchanged Prior quarter: 668,830Open filing 0001193125-26-461853 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager659,340 SH5,643,951 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager639,500 SH5,474,120 dollarsHigher by 34,200 Prior quarter: 605,300Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
LexAurum Advisors, LLC 633,533 SH5,423,042 dollarsLower by 4,880 Prior quarter: 638,413Open filing 0001729677-26-000012 Filed 2026-10-19 Dispute this row
Trexquant Investment LP Partly reported under another manager581,264 SH4,975,620 dollarsNot in the prior quarter’s filings read Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager515,956 SH4,416,584 dollarsLower by 376 Prior quarter: 516,332Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
Lansing Street Advisors 498,519 SH4,267,323 dollarsHigher by 3,097 Prior quarter: 495,422Open filing 0001926571-26-000005 Filed 2026-11-12 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager484,581 SH4,148,000 dollarsHigher by 337,565 Prior quarter: 147,016Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager483,966 SH4,142,746 dollarsHigher by 9,469 Prior quarter: 474,497Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Informed Momentum Co LLC 470,402 SH4,026,641 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-127619 Filed 2026-11-16 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager459,783 SH3,935,740 dollarsHigher by 402,901 Prior quarter: 56,882Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
Swiss National Bank 396,500 SH3,394,040 dollarsHigher by 5,900 Prior quarter: 390,600Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 1,515,853 SH
  • Caption Management, LLC 900,000 SH
  • Squarepoint Ops LLC 353,272 SH
  • ExodusPoint Capital Management, LP 311,930 SH
  • SIMPLEX TRADING, LLC 249,007 SH
  • Shay Capital LLC 190,000 SH
  • DIADEMA PARTNERS LP 135,293 SH
  • Shay Capital LLC 120,000 SH
  • AXQ CAPITAL, LP 116,978 SH
  • Integrated Quantitative Investments LLC 90,655 SH
  • Jupiter Topco LLC 89,000 SH
  • AMERICAN FINANCIAL GROUP INC 66,114 SH
  • SG Americas Securities, LLC 53,548 SH
  • INTECH INVESTMENT MANAGEMENT LLC 37,418 SH
  • Occam Crest Management LP 35,500 SH
  • Balyasny Asset Management L.P. 32,283 SH
  • PEAK6 LLC 30,000 SH
  • Summit Trail Advisors, LLC 29,577 SH
  • Fulcrum Asset Management LLP 20,254 SH
  • Wellington Shields Co., LLC 17,000 SH
  • Integrated Wealth Concepts LLC 12,843 SH
  • Headlands Technologies LLC 11,547 SH
  • DRW Securities, LLC 10,854 SH
  • Pacer Advisors, Inc. 3,289 SH
  • Federation des caisses Desjardins du Quebec 1,000 SH
  • AdvisorNet Financial, Inc 660 SH
  • Truvestments Capital LLC 578 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 200 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Ares Trading SA Common Stock4.917,467,152.0006/09/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 6Open filing 0001104659-26-092515 Dispute this row
Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadt Common Stock4.917,467,152.0006/09/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 6Open filing 0001104659-26-092515 Dispute this row
Merck KGaA, Darmstadt, Germany Common Stock4.917,467,152.0006/09/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 6Open filing 0001104659-26-092515 Dispute this row
E. Merck KG, Darmstadt Germany Common Stock4.917,467,152.0006/09/2026 Filed 2026-08-07SCHEDULE 13G/AAmendment 6Open filing 0001104659-26-092515 Dispute this row
Point72 Asset Management, L.P. Common Stock, no par value per share1.96,741,861.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003505 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, no par value per share1.96,741,861.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003505 Dispute this row
Steven A. Cohen Common Stock, no par value per share1.96,741,861.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003505 Dispute this row
RANDAL J. KIRK Common Stock35.9133,956,416.0003/30/2026 Filed 2026-03-31SCHEDULE 13D/AAmendment 22Open filing 0001213900-26-037403 Dispute this row
R.J. KIRK DECLARATION OF TRUST Common Stock26.197,339,485.0003/30/2026 Filed 2026-03-31SCHEDULE 13D/AAmendment 22Open filing 0001213900-26-037403 Dispute this row
THIRD SECURITY, LLC Common Stock5.921,843,458.0003/30/2026 Filed 2026-03-31SCHEDULE 13D/AAmendment 22Open filing 0001213900-26-037403 Dispute this row
Point72 Asset Management, L.P. Common Stock, no par value per share5.218,383,242.0001/22/2026 Filed 2026-01-23SCHEDULE 13GOpen filing 0000902664-26-000427 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, no par value per share5.218,383,242.0001/22/2026 Filed 2026-01-23SCHEDULE 13GOpen filing 0000902664-26-000427 Dispute this row
Steven A. Cohen Common Stock, no par value per share5.218,383,242.0001/22/2026 Filed 2026-01-23SCHEDULE 13GOpen filing 0000902664-26-000427 Dispute this row
Patient Capital Management, LLC Common Stock10.236,006,80012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 4Open filing 0001854794-26-000001 Dispute this row
Patient Opportunity Trust, a Series of Advisor Managed Portfolios Common Stock7.827,617,61212/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 4Open filing 0001854794-26-000001 Dispute this row
RANDAL J. KIRK Common Stock38.1141,519,399.0011/19/2025 Filed 2025-11-21SCHEDULE 13D/AAmendment 21Open filing 0001213900-25-113780 Dispute this row
R.J. KIRK DECLARATION OF TRUST Common Stock26.698,831,434.0011/19/2025 Filed 2025-11-21SCHEDULE 13D/AAmendment 21Open filing 0001213900-25-113780 Dispute this row
THIRD SECURITY, LLC Common Stock6.624,487,991.0011/19/2025 Filed 2025-11-21SCHEDULE 13D/AAmendment 21Open filing 0001213900-25-113780 Dispute this row
RANDAL J. KIRK Common Stock39.4146,295,359.0009/17/2025 Filed 2025-09-19SCHEDULE 13D/AAmendment 20Open filing 0001213900-25-089729 Dispute this row
R.J. KIRK DECLARATION OF TRUST Common Stock26.698,831,434.0009/17/2025 Filed 2025-09-19SCHEDULE 13D/AAmendment 20Open filing 0001213900-25-089729 Dispute this row
SUNSET 2020 LLC Common Stock4.416,406,828.0009/17/2025 Filed 2025-09-19SCHEDULE 13D/AAmendment 20Open filing 0001213900-25-089729 Dispute this row
THIRD SECURITY, LLC Common Stock7.427,454,284.0009/17/2025 Filed 2025-09-19SCHEDULE 13D/AAmendment 20Open filing 0001213900-25-089729 Dispute this row
William H. Miller III Living Trust dated April 17, 2017 Common Stock9.234,051,925.0006/26/2025 Filed 2025-09-23SCHEDULE 13GOpen filing 0002071876-25-000050 Dispute this row
Patient Capital Management, LLC Common Stock13.645,223,463.0012/31/2024 Filed 2025-10-30SCHEDULE 13G/AAmendment 3Open filing 0001085146-25-005965 Dispute this row
Patient Opportunity Trust, a Series of Advisor Managed Portfolios Common Stock1135,786,370.0012/31/2024 Filed 2025-10-30SCHEDULE 13G/AAmendment 3Open filing 0001085146-25-005965 Dispute this row
RANDAL J. KIRK Common Stock39.8116,844,357.0012/30/2024 Filed 2024-12-30SCHEDULE 13D/AAmendment 19Open filing 0001213900-24-113602 Dispute this row
R.J. KIRK DECLARATION OF TRUST Common Stock22.064,547,214.0012/30/2024 Filed 2024-12-30SCHEDULE 13D/AAmendment 19Open filing 0001213900-24-113602 Dispute this row
SUNSET 2020 LLC Common Stock5.616,406,828.0012/30/2024 Filed 2024-12-30SCHEDULE 13D/AAmendment 19Open filing 0001213900-24-113602 Dispute this row
THIRD SECURITY, LLC Common Stock11.132,454,536.0012/30/2024 Filed 2024-12-30SCHEDULE 13D/AAmendment 19Open filing 0001213900-24-113602 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,728,591 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015144,973
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to PRECIGEN, INC.